Breaks Categories: News

TuesdaySep 17, 2019 10:29 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Partners with John Legend and Casper in Nationwide Launch of 100% Hemp CBD Product Line

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company in California, this morning announced the nationwide launch of its first-ever 100% hemp CBD product line. According to the update, a newly established brand partnership between PLUS and American superstar and philanthropist John Legend supports the launch, and Legend will advocate on behalf of the company’s new nationwide hemp CBD product offering. “I have been a believer in the benefits of CBD for some time,” stated Legend. “I was drawn to the PLUS team because they're an innovative, family-run company, and they use science to deliver a consistent,…

Continue Reading

TuesdaySep 17, 2019 10:17 am

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Announces Partnership with Linneo Health to Supply Medical Cannabis in Europe

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) this morning announced that it has engaged with Linneo Health S.L., a subsidiary of Alcaliber S.A., to be its European medical cannabis supply partner. A European leader in the pharmaceutical cannabis industry, Linneo Health recently received its EU-GMP (“Good Manufacturing Practices”) certification from the Spanish regulatory authorities. According to the update, the multi-year agreement includes increasing supply volumes as VIVO expands in the European medical market. "Our partnership with Linneo Health is part of our strategic priority to accelerate international market growth," VIVO CEO Barry Fishman said in the news release. "We are…

Continue Reading

TuesdaySep 17, 2019 10:03 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Enters Distribution Agreement to Launch Medical Cannabis Inhaler in Canada

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has entered into a distribution agreement with Israel-based pharma-tech company Syqe Medical, Ltd. to launch Syqe's flagship product, the Syqe(TM) Inhaler, in Canada. The Syqe Inhaler is a metered-dose medical cannabis inhaler that provides quick pain relief while decreasing psychoactive effects and enabling patients to go about their normal daily activities. The inhaler’s use of metered dosing allows patients and healthcare providers to consistently deliver treatment at pharmaceutical standards. Through its wholly owned subsidiaries, TerrAscend…

Continue Reading

ThursdaySep 12, 2019 10:33 am

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Accelerate Shipments to Meet Demand for Premium Organic Cannabis Following Ontario Launch

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, today announced that initial demand has exceeded expectations following its August launch in Ontario, which marked the company's entrance into Canada's recreational market. Per the update, TGOD's Unite Organic, a high-THC signature strain, is performing well online and at dispensaries and triggering a second OCS order earlier than initially anticipated. “We are thrilled to witness such strong sales and positive feedback from retailers and consumers across Ontario, Canada's most populous province at 14.32 million people.  We can see…

Continue Reading

ThursdaySep 12, 2019 10:26 am

CannabisNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Launches New Exclusive CBD Brand

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced the launch of its new exclusive brand of cannabidiol (“CBD”) product lines: BIS (“Be In Synergy”). According to the update, the mission to develop innovative, high quality, efficient and safe consumer products through unique formulations and technologies that optimize the use and effects of cannabis drove creation of the new brand. “Nabis has always been dedicated to the development and distribution of only the highest quality products,” Nabis CEO and Director Shay Shnet…

Continue Reading

ThursdaySep 12, 2019 9:51 am

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Enters Agreement for Debt Private Placement

Plus Products (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in California, on Wednesday announced its entry into an agreement with a certain arm’s length party with respect to the settlement of USD$1,044,806.03 owing or to be owing to such creditor for services rendered. Plus Products has agreed, as payment in full of such amount, to issue to the creditor or its assignee 318,471 units of the company, each at a deemed price of CAD$4.32. Each unit consists of one subordinate voting share in the capital of the company and one warrant. Until five years from the date…

Continue Reading

WednesdaySep 11, 2019 9:40 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Formation of Strategic Advisory Board

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the formation of its Strategic Advisory Board. According to the update, the group of respected business leaders, which includes inaugural board members John Ruffolo, Meg Lovell and Philip Donne, will provide guidance to Canopy Rivers’ executive team as it continues to build and strengthen its global portfolio of leading cannabis companies. “We have assembled a group of outstanding individuals with exceptional track records as leaders in their respective industries,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “The Strategic Advisory Board…

Continue Reading

TuesdaySep 10, 2019 11:49 am

CannabisNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: A2PL) Acquires Cultivation, Fulfillment and Production Facility, Expands Arizona Footprint

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: A2PL), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, today announced the closing of its acquisition of a 44,000 square foot cultivation, production and fulfillment facility located in Camp Verde, Arizona near Phoenix. This is the company’s second announced acquisition in the state of Arizona following its definitive agreement to acquire a licensed medical marijuana business including a Phoenix dispensary. “We are excited to progress on our growth strategy in Arizona with the purchase of the Camp Verde facility in keeping with  our mission…

Continue Reading

TuesdaySep 10, 2019 10:30 am

CannabisNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) Herbert Works Awarded Health Canada R&D License to Develop Cannabis-Infused Beverages

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company Herbert Works Ltd. has received its Health Canada research and development (R&D) license to develop branded cannabis-infused beverages. “This announcement represents a significant milestone for Herbert Works as the company continues to move quickly toward the development of exceptional and widely appealing THC-infused beverages,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “It's a timely achievement, as the next wave of cannabis legalization in Canada will unlock these new product offerings in a matter of months. We…

Continue Reading

TuesdaySep 10, 2019 9:58 am

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Announces Stock Option Grant and Unit Issuance

Willow Biosciences Inc. (CSE: WLLW) on Tuesday announced that it has granted an aggregate of 1,118,000 stock options for certain employees to purchase common shares of Willow pursuant to the terms and conditions of its stock option plan. According to the update, the options expire five years from the grant date, are exercisable at a price of $0.60 per common share, and vest as to one third on the grant date and on each of the first and second anniversaries of the grant date. Willow has additionally issued 21,057 units of the company in connection with its previous April 2019…

Continue Reading